CAD 0.5
(25.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.05 Million CAD | 477.83% |
2022 | 528.16 Thousand CAD | 266.26% |
2021 | 144.2 Thousand CAD | -10.72% |
2020 | 161.51 Thousand CAD | 29.18% |
2019 | 125.02 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 4.05 Million CAD | 16.49% |
2024 Q1 | 3.47 Million CAD | 13.98% |
2023 Q3 | 648.97 Thousand CAD | -14.35% |
2023 FY | 3.05 Million CAD | 477.83% |
2023 Q4 | 3.05 Million CAD | 370.26% |
2023 Q2 | 757.67 Thousand CAD | 48.25% |
2023 Q1 | 511.08 Thousand CAD | -3.23% |
2022 Q1 | 78.85 Thousand CAD | -45.32% |
2022 Q3 | 965.78 Thousand CAD | 292.01% |
2022 Q2 | 246.36 Thousand CAD | 212.45% |
2022 FY | 528.16 Thousand CAD | 266.26% |
2022 Q4 | 528.16 Thousand CAD | -45.31% |
2021 FY | 144.2 Thousand CAD | -10.72% |
2021 Q4 | 144.2 Thousand CAD | -95.74% |
2021 Q3 | 3.38 Million CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | 2.71 Million CAD | -12.211% |
BetterLife Pharma Inc. | 8.02 Million CAD | 61.949% |
BioVaxys Technology Corp. | 3.48 Million CAD | 12.442% |
ChitogenX Inc. | 6.71 Million CAD | 54.531% |
Rapid Dose Therapeutics Corp. | 5.04 Million CAD | 39.485% |
Defence Therapeutics Inc. | 4.06 Million CAD | 24.868% |
Entheon Biomedical Corp. | 85.32 Thousand CAD | -3476.707% |
Gemina Laboratories Ltd. | 3.04 Million CAD | -0.341% |
Glow Lifetech Corp. | 2.34 Million CAD | -30.08% |
Lexston Life Sciences Corp. | 39.86 Thousand CAD | -7554.722% |
Pharmala Biotech Holdings Inc. | 1.02 Million CAD | -196.579% |
Doseology Sciences Inc. | 82.49 Thousand CAD | -3599.584% |
MYND Life Sciences Inc. | 5.77 Million CAD | 47.151% |
Nova Mentis Life Science Corp. | 841.66 Thousand CAD | -262.599% |
PharmaTher Holdings Ltd. | 252.9 Thousand CAD | -1106.741% |
PreveCeutical Medical Inc. | 5.95 Million CAD | 48.792% |
Telescope Innovations Corp. | 1.35 Million CAD | -125.892% |